
How to combine growth hormone secretagogues, fat loss peptides, and recovery compounds for maximum body recomposition.
Body recomposition, simultaneously losing fat and gaining muscle, is the holy grail of physique optimization. Peptides offer a uniquely powerful toolkit for achieving this goal, particularly when combined strategically into synergistic stacks.
Body recomposition, the simultaneous loss of body fat and gain of lean muscle mass, is notoriously difficult to achieve through diet and training alone, particularly for men who are already reasonably lean and well trained. The conventional wisdom that you must choose between a bulk and a cut ignores the powerful role that hormonal optimization plays in determining body composition. Peptide stacks, when used intelligently alongside a structured training program and dialed in nutrition, can meaningfully shift this equation in your favor.
This guide breaks down the most effective peptide stacks for body recomposition in 2026, covering the science behind each combination, precise dosing protocols, expected timelines, and what to realistically expect from each approach.
12 to 16 wks
Typical Recomp Cycle
peptide assisted
3 to 5%
Body Fat Reduction
average over 12 weeks
+2 to 4 lbs
Lean Mass Gain
concurrent with fat loss
2x
GH Pulse Increase
CJC-1295 + Ipamorelin
The fundamental challenge of body recomposition is that fat loss and muscle gain require opposing hormonal environments, fat loss favors a caloric deficit and elevated catecholamines, while muscle gain favors a caloric surplus and elevated anabolic hormones. Peptides, particularly growth hormone secretagogues, help resolve this tension by elevating GH and IGF-1 levels, which simultaneously promote lipolysis (fat breakdown) and protein synthesis (muscle building). This dual action is the key to why peptide assisted recomposition outperforms traditional approaches.
The cornerstone of any serious recomposition peptide stack is a growth hormone secretagogue combination. The most effective and best tolerated pairing is CJC-1295 (with DAC) combined with Ipamorelin.
CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that has been modified with a Drug Affinity Complex (DAC) to extend its half life from minutes to approximately 6 to 8 days. This extended half life allows for once weekly dosing while maintaining elevated GH levels throughout the week. CJC-1295 works by binding to GHRH receptors in the pituitary gland, stimulating the synthesis and release of growth hormone.
Ipamorelin is a selective growth hormone secretagogue that binds to the ghrelin receptor (GHS-R1a) in the pituitary, triggering a strong, clean pulse of GH release. Its key advantage over other GH secretagogues is its selectivity, it stimulates GH release without significantly increasing cortisol, prolactin, or ACTH, all of which can blunt the anabolic effects of GH elevation. This makes it the preferred GH secretagogue for athletes and physique focused men.
CJC-1295 + Ipamorelin Stack Protocol
| Peptide | Dose | Timing | Frequency | Notes |
|---|---|---|---|---|
| CJC-1295 w/ DAC | 2 mg | Any time | Once weekly | Long half life; once weekly is sufficient |
| Ipamorelin | 200 to 300 mcg | Upon waking (fasted) | Daily | Take on empty stomach for best absorption |
| Ipamorelin | 200 to 300 mcg | 30 min pre workout | Daily (training days) | Amplifies GH pulse with exercise |
| Ipamorelin | 200 to 300 mcg | Before bed | Daily | Maximizes nocturnal GH release |
AOD-9604 is a modified fragment of the human growth hormone molecule, specifically amino acids 176 to 191 of the HGH C-terminus. This fragment retains the lipolytic (fat burning) properties of full HGH without the insulin desensitizing effects that make exogenous HGH problematic for metabolic health. AOD-9604 directly stimulates fat cell breakdown and inhibits the formation of new fat cells, making it an ideal addition to a recomposition stack.
The standard protocol for AOD-9604 is 300 mcg administered subcutaneously in the morning in a fasted state. The fasted state is important because elevated insulin levels blunt AOD-9604's lipolytic effects. AOD-9604 has been studied in Phase II and III clinical trials for obesity, demonstrating a favorable safety profile with no effects on blood glucose or insulin sensitivity.
Any serious recomposition protocol involves increased training volume and intensity, which elevates injury risk. BPC-157 at 250 mcg per day (subcutaneous) provides a protective and recovery enhancing effect that allows you to train harder and more consistently without accumulating overuse injuries. It also supports gut health, which is critical for nutrient absorption during a recomposition phase where dietary precision matters.
Full Recomposition Protocol
| Peptide | Dose | Timing | Frequency | Purpose |
|---|---|---|---|---|
| CJC-1295 w/ DAC | 2 mg | Any time | Once weekly | Sustained GH elevation |
| Ipamorelin | 200 to 300 mcg | Fasted AM + pre bed | 2 to 3x daily | GH pulse amplification |
| AOD-9604 | 300 mcg | Fasted AM | Once daily | Targeted fat oxidation |
| BPC-157 | 250 mcg | Any time | Once daily | Recovery + gut health |
Setting realistic expectations is critical for staying consistent with any protocol. Here is what most men experience on this stack:
This recomposition stack is best suited for men who are already lean (sub-15% body fat), have at least 2 years of consistent resistance training, and have their nutrition fundamentals in place. Peptides amplify the results of good habits, they do not replace them. If your training is inconsistent or your diet is poor, the results will be proportionally limited.
For men primarily focused on fat loss rather than muscle gain, a combination of AOD-9604 (300 mcg, AM fasted) + Tesamorelin (1 to 2 mg, before bed) + BPC-157 (250 mcg, daily) is highly effective. Tesamorelin is a GHRH analogue that has been FDA approved for HIV associated lipodystrophy and has demonstrated significant visceral fat reduction in clinical trials.
For men in a caloric surplus focused on maximizing lean mass gains while minimizing fat accumulation, CJC-1295 + Ipamorelin + MK-677 (an oral GH secretagogue) creates a powerful anabolic environment. Note that MK-677 significantly increases appetite and may cause water retention, making it better suited to a lean bulk than a recomposition phase.
Medical Disclaimer
The information in this article is for educational purposes only and does not constitute medical advice. Peptides are not approved by the FDA for the uses described. Consult a qualified healthcare provider before beginning any peptide protocol.
Continue Reading

BPC-157: The Complete Guide to Dosing, Benefits, and Results (2026)
14 min read

Sermorelin vs. Ipamorelin: Which GH Peptide Is Right for You? (2026 Guide)
15 min read

Beginner's Guide to Peptides: Everything You Need to Know Before Starting (2026)
18 min read